» Articles » PMID: 29686695

Sequence Analysis of Among the Kuwaiti Population Identifies Association of Rs2072560, Rs2266788, and Rs662799 With TG and VLDL Levels

Overview
Journal Front Genet
Date 2018 Apr 25
PMID 29686695
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Common variants of Apolipoprotein A5 (5) have been associated with lipid levels yet very few studies have reported full sequence data from various ethnic groups. The purpose of this study was to analyse the full gene sequence to identify variants in 100 healthy Kuwaitis of Arab ethnicities and assess their association with variation in lipid levels in a cohort of 733 samples. Sanger method was used in the direct sequencing of the full 3.7 Kb and multiple sequence alignment was used to identify variants. The complete sequence in Kuwaiti Arabs has been deposited in GenBank (KJ401315). A total of 20 reported single nucleotide polymorphisms (SNPs) were identified. Two novel SNPs were also identified: a synonymous 2197G>A polymorphism at genomic position 116661525 and a 3' UTR 3222 C>T polymorphism at genomic position 116660500 based on human genome assembly GRCh37/hg:19. Five SNPs along with the two novel SNPs were selected for validation in the cohort. Association of those SNPs with lipid levels was tested and minor alleles of three SNPs (rs2072560, rs2266788, and rs662799) were found significantly associated with TG and VLDL levels. This is the first study to report the full sequence and SNPs in an Arab ethnic group. Analysis of the variants identified and comparison to other populations suggests a distinctive genetic component in Arabs. The positive association observed for rs2072560 and rs2266788 with TG and VLDL levels confirms their role in lipid metabolism.

Citing Articles

Consumption of dietary fiber and APOA5 genetic variants in metabolic syndrome: baseline data from the Korean Medicine Daejeon Citizen Cohort Study.

Kim J, Baek Y, Lee S Nutr Metab (Lond). 2024; 21(1):19.

PMID: 38581036 PMC: 10998362. DOI: 10.1186/s12986-024-00793-0.


Sequence Variant Analysis of the Locus among an Arab Cohort.

Al-Bustan S, Alrashid M, Al-Serri A, Annice B, Bahbahani H Int J Mol Sci. 2023; 24(22).

PMID: 38003484 PMC: 10671382. DOI: 10.3390/ijms242216293.


Regularized Machine Learning Models for Prediction of Metabolic Syndrome Using and Gene Variants: Tehran Cardiometabolic Genetic Study.

Alipour N, Kazemnejad A, Akbarzadeh M, Eskandari F, Zahedi A, Daneshpour M Cell J. 2023; 25(8):536-545.

PMID: 37641415 PMC: 10542204. DOI: 10.22074/cellj.2023.2000864.1294.


A Clinical Case of a Homozygous Deletion in the Gene with Severe Hypertriglyceridemia.

Vasiluev P, Ivanova O, Semenova N, Strokova T, Taran N, Chubykina U Genes (Basel). 2022; 13(6).

PMID: 35741823 PMC: 9222921. DOI: 10.3390/genes13061062.


Exome Sequencing Data Analysis and a Case-Control Study in Mexican Population Reveals Lipid Trait Associations of New and Known Genetic Variants in Dyslipidemia-Associated Loci.

Jurado-Camacho P, Cid-Soto M, Barajas-Olmos F, Garcia-Ortiz H, Baca-Peynado P, Martinez-Hernandez A Front Genet. 2022; 13:807381.

PMID: 35669185 PMC: 9164108. DOI: 10.3389/fgene.2022.807381.


References
1.
Ouatou S, Ajjemami M, Charoute H, Sefri H, Ghalim N, Rhaissi H . Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients. Lipids Health Dis. 2014; 13:60. PMC: 3972990. DOI: 10.1186/1476-511X-13-60. View

2.
Zubair N, Graff M, Ambite J, Bush W, Kichaev G, Lu Y . Fine-mapping of lipid regions in global populations discovers ethnic-specific signals and refines previously identified lipid loci. Hum Mol Genet. 2017; 25(24):5500-5512. PMC: 5721937. DOI: 10.1093/hmg/ddw358. View

3.
Excoffier L, Ray N . Surfing during population expansions promotes genetic revolutions and structuration. Trends Ecol Evol. 2008; 23(7):347-51. DOI: 10.1016/j.tree.2008.04.004. View

4.
Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

5.
Schaap F, Rensen P, Voshol P, Vrins C, van der Vliet H, Chamuleau R . ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem. 2004; 279(27):27941-7. DOI: 10.1074/jbc.M403240200. View